皮膚充填剤市場規模、シェア、業界分析および予測　2024-2032年

皮膚充填剤市場 : 素材（ヒアルロン酸、カルシウムヒドロキシアパタイト、ポリL乳酸、PMMA（ポリメチルメタクリレート）、脂肪充填剤など）、製品別（生分解性および非生分解性）、用途別（傷跡治療、しわ矯正治療、唇の増強、ボリューム/ふっくら感の回復など）、エンドユーザー別（専門医および皮膚科クリニック、病院およびクリニックなど）、および地域別の市場規模、シェア、業界分析および予測　2024-2032年

Growth Factors of Dermal Fillers Market

The global dermal fillers market size was valued at USD 5.16 billion in 2022 and is projected to grow from USD 5.49 billion in 2023 to USD 9.93 billion by 2030, exhibiting a CAGR of 8.7% during the forecast period. This growth is attributed to the rising demand for aesthetic treatments, increasing awareness about cosmetic procedures, and a growing aging population seeking non-invasive anti-aging solutions.

世界の皮膚充填剤市場規模は2022年に51億6,000万米ドルと評価され、2023年の54億9,000万米ドルから2030年には99億3,000万米ドルに拡大すると予測されており、予測期間中は年平均成長率（CAGR）8.7%で成長すると見込まれています。この成長は、美容治療への需要の高まり、美容施術に対する意識の高まり、そして非侵襲的なアンチエイジングソリューションを求める高齢化人口の増加に起因しています。

Rising Demand for Aesthetic Procedures

Over the past decade, the perception of beauty enhancement and aesthetic appearance has undergone a significant shift. An increasing number of people are opting for minimally invasive and non-surgical procedures to improve facial appearance, skin texture, and volume loss due to aging. Dermal fillers, often referred to as soft tissue fillers, are commonly used to restore lost volume, smooth lines, and soften creases.

One of the most significant drivers behind this market is the rising popularity of hyaluronic acid-based fillers, which offer immediate and natural-looking results with minimal recovery time. These fillers are FDA-approved and are widely used to treat wrinkles, facial folds, and enhance lips and cheeks.

The growing influence of social media and the desire to achieve ideal beauty standards are also encouraging millennials and Gen Z to explore aesthetic enhancements at an early age, further expanding the market.

Technological Advancements in Products

The market is witnessing innovation in terms of product formulations and delivery systems. Companies are investing heavily in R&D to develop longer-lasting, safer, and more customizable fillers. Biodegradable fillers made from natural substances like collagen, calcium hydroxylapatite, and poly-L-lactic acid are gaining traction due to their favorable safety profiles.

Moreover, advancements in injection techniques, cannula-based administration, and AI-assisted facial analysis are ensuring better patient outcomes and reduced side effects. These developments are playing a vital role in attracting new customers and ensuring repeat usage.

Growing Medical Tourism and Dermatology Clinics

Countries such as South Korea, Thailand, Mexico, and Turkey are emerging as hotspots for aesthetic medical tourism. Cost-effective treatment packages, skilled dermatologists, and world-class facilities are encouraging international patients to undergo dermal filler procedures abroad.

In developed countries, an increase in specialized dermatology and aesthetic clinics equipped with certified professionals is contributing to the market’s expansion. The convenience of quick, outpatient-based treatments with visible results adds to the appeal.

Regional Insights

North America held the largest market share in 2022, primarily due to high consumer spending on cosmetic procedures, the presence of leading players, and an established regulatory framework. The U.S. market continues to lead the region, driven by technological innovation and growing acceptance of aesthetic procedures.

Europe is another significant region, with countries like Germany, the U.K., and France at the forefront of aesthetic advancements. Cultural acceptance of cosmetic treatments and strong healthcare infrastructure support market growth.

Asia Pacific is expected to witness the fastest growth during the forecast period. Rising disposable incomes, increasing awareness of personal grooming, and the popularity of K-beauty trends are contributing to the surge in demand. China, Japan, and South Korea are the primary markets in this region.

Key Players and Strategic Developments

Several major players dominate the global dermal fillers market, and they are continuously engaged in strategies such as product launches, mergers, acquisitions, and partnerships to expand their global presence. Notable companies include:

• Allergan (AbbVie Inc.)
• Revance Therapeutics, Inc.
• Ipsen
• Medytox
• Sinclair Pharma
• Hugel, Inc.
• Bloomage Biotechnology Corporation Limited
• Teoxane Laboratories
• BIOPLUS CO., LTD.

The acquisition of Allergan by AbbVie has significantly consolidated market leadership in the aesthetics segment, while companies like Teoxane and Revance are expanding their footprint in new geographies through regulatory approvals and distribution networks.

Conclusion

The dermal fillers market is experiencing robust growth due to shifting beauty standards, advancements in aesthetic medicine, and increasing demand for non-invasive cosmetic treatments. With technology and social trends evolving rapidly, the market is poised to witness further innovation and geographic expansion. The combination of safety, convenience, and immediate results continues to position dermal fillers as a key pillar in the aesthetic healthcare sector.

ATTRIBUTE        DETAILS

Study Period          2019-2032

Base Year               2023

Estimated Year      2024

Forecast Period     2024-2032

Historical Period  2019-2022

Growth Rate          CAGR of 8.1% from 2024-2032

Unit        Value (USD Billion)

Segmentation

By Material

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• PMMA (Poly (Methyl Methacrylate))
• Fat Fillers
• Others

By Product

• Biodegradable
• Non-Biodegradable

By Application

• Scar Treatment
• Wrinkle Correction Treatment
• Lip Enhancement
• Restoration of Volume/Fullness
• Others

By End-user

• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Others

By Region

• North America (By Material, Product, Application, End-user, and Country)

o               U.S. (By Material)

o               Canada (By Material)

• Europe (By Material, Product, Application, End-user, and Country/Sub-Region)

o               U.K. (By Material)

o               Germany (By Material)

o               France (By Material)

o               Spain (By Material)

o               Italy (By Material)

o               Scandinavia (By Material)

o               Rest of Europe (By Material)

• Asia Pacific (By Material, Product, Application, End-user, and Country/Sub-Region)

o               Japan (By Material)

o               China (By Material)

o               India (By Material)

o               Australia (By Material)

o               South Korea (By Material)

o               Southeast Asia (By Material)

o               Rest of Asia Pacific (By Material)

• Latin America (By Material, Product, Application, End-user, and Country/Sub-Region)

o               Brazil (By Material)

o               Mexico (By Material)

o               Rest of Latin America (By Material)

• Middle East & Africa (By Material, By Product, By Application, By End-user, By Country/Sub-Region)

o               Egypt (By Material)

o               Iran (By Material)

o               Turkey (By Material)

o               Lebanon (By Material)

o               UAE (By Material)

o               Saudi Arabia (By Material)

o               South Africa (By Material)

o               Rest of the Middle East & Africa (By Material)

Table of Contents

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Overview of the Number of Dermal Fillers Procedures, By Key Countries
4.2. Overview of Price Analysis of Types of Dermal Fillers
4.3. Overview of Regulatory Scenario, By Key Countries
4.4. Overview of Reimbursement Scenario, By Key Countries
4.5. New Product Launches, By Key Players
4.6. Pipeline Analysis
4.7. Impact of COVID-19 on Dermal Fillers Market
5. Global Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Material
5.1.1. Hyaluronic Acid
5.1.2. Calcium Hydroxylapatite
5.1.3. Poly-L-lactic Acid
5.1.4. PMMA (Poly(methyl methacrylate))
5.1.5. Fat Fillers
5.1.6. Others
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1. Biodegradable
5.2.2. Non-Biodegradable
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Scar Treatment
5.3.2. Wrinkle Correction Treatment
5.3.3. Lip Enhancement
5.3.4. Restoration of Volume/ Fullness
5.3.5. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Specialty & Dermatology Clinics
5.4.2. Hospitals & Clinics
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Material
6.1.1. Hyaluronic Acid
6.1.2. Calcium Hydroxylapatite
6.1.3. Poly-L-lactic Acid
6.1.4. PMMA (Poly(methyl methacrylate))
6.1.5. Fat Fillers
6.1.6. Others
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1. Biodegradable
6.2.2. Non-Biodegradable
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1. Scar Treatment
6.3.2. Wrinkle Correction Treatment
6.3.3. Lip Enhancement
6.3.4. Restoration of Volume/ Fullness
6.3.5. Others
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Specialty & Dermatology Clinics
6.4.2. Hospitals & Clinics
6.4.3. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.1.1. By Material
6.5.2. Canada
6.5.2.1. By Material
7. Europe Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Material
7.1.1. Hyaluronic Acid
7.1.2. Calcium Hydroxylapatite
7.1.3. Poly-L-lactic Acid
7.1.4. PMMA (Poly(methyl methacrylate))
7.1.5. Fat Fillers
7.1.6. Others
7.2. Market Analysis, Insights and Forecast – By Product
7.2.1. Biodegradable
7.2.2. Non-Biodegradable
7.3. Market Analysis, Insights and Forecast – By Application
7.3.1. Scar Treatment
7.3.2. Wrinkle Correction Treatment
7.3.3. Lip Enhancement
7.3.4. Restoration of Volume/ Fullness
7.3.5. Others
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Specialty & Dermatology Clinics
7.4.2. Hospitals & Clinics
7.4.3. Others
7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.5.1. U.K.
7.5.1.1. By Material
7.5.2. Germany
7.5.2.1. By Material
7.5.3. France
7.5.3.1. By Material
7.5.4. Spain
7.5.4.1. By Material
7.5.5. Italy
7.5.5.1. By Material
7.5.6. Scandinavia
7.5.6.1. By Material
7.5.7. Rest of Europe
7.5.7.1. By Material
8. Asia Pacific Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Material
8.1.1. Hyaluronic Acid
8.1.2. Calcium Hydroxylapatite
8.1.3. Poly-L-lactic Acid
8.1.4. PMMA (Poly(methyl methacrylate))
8.1.5. Fat Fillers
8.1.6. Others
8.2. Market Analysis, Insights and Forecast – By Product
8.2.1. Biodegradable
8.2.2. Non-Biodegradable
8.3. Market Analysis, Insights and Forecast – By Application
8.3.1. Scar Treatment
8.3.2. Wrinkle Correction Treatment
8.3.3. Lip Enhancement
8.3.4. Restoration of Volume/ Fullness
8.3.5. Others
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Specialty & Dermatology Clinics
8.4.2. Hospitals & Clinics
8.4.3. Others
8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.5.1. Japan
8.5.1.1. By Material
8.5.2. China
8.5.2.1. By Material
8.5.3. India
8.5.3.1. By Material
8.5.4. Australia
8.5.4.1. By Material
8.5.5. Southeast Asia
8.5.5.1. By Material
8.5.6. Rest of Asia Pacific
8.5.6.1. By Material
9. Latin America Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Material
9.1.1. Hyaluronic Acid
9.1.2. Calcium Hydroxylapatite
9.1.3. Poly-L-lactic Acid
9.1.4. PMMA (Poly(methyl methacrylate))
9.1.5. Fat Fillers
9.1.6. Others
9.2. Market Analysis, Insights and Forecast – By Product
9.2.1. Biodegradable
9.2.2. Non-Biodegradable
9.3. Market Analysis, Insights and Forecast – By Application
9.3.1. Scar Treatment
9.3.2. Wrinkle Correction Treatment
9.3.3. Lip Enhancement
9.3.4. Restoration of Volume/ Fullness
9.3.5. Others
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Specialty & Dermatology Clinics
9.4.2. Hospitals & Clinics
9.4.3. Others
9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
9.5.1. Brazil
9.5.1.1. By Material
9.5.2. Mexico
9.5.2.1. By Material
9.5.3. Rest of Latin America
9.5.3.1. By Material
10. Middle East & Africa Dermal Fillers Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Material
10.1.1. Hyaluronic Acid
10.1.2. Calcium Hydroxylapatite
10.1.3. Poly-L-lactic Acid
10.1.4. PMMA (Poly(methyl methacrylate))
10.1.5. Fat Fillers
10.1.6. Others
10.2. Market Analysis, Insights and Forecast – By Product
10.2.1. Biodegradable
10.2.2. Non-Biodegradable
10.3. Market Analysis, Insights and Forecast – By Application
10.3.1. Scar Treatment
10.3.2. Wrinkle Correction Treatment
10.3.3. Lip Enhancement
10.3.4. Restoration of Volume/ Fullness
10.3.5. Others
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Specialty & Dermatology Clinics
10.4.2. Hospitals & Clinics
10.4.3. Others
10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
10.5.1. Egypt
10.5.1.1. By Material
10.5.2. Iran
10.5.2.1. By Material
10.5.3. Turkey
10.5.3.1. By Material
10.5.4. Lebanon
10.5.4.1. By Material
10.5.5. UAE
10.5.5.1. By Material
10.5.6. Saudi Arabia
10.5.6.1. By Material
10.5.7. South Africa
10.5.7.1. By Material
10.5.8. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Allergan (AbbVie, Inc.)
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Revance Therapeutics, Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Merz Pharma
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Galderma laboratories
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Sinclair Pharma
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. BioPlus Co., Ltd.
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Bioxis pharmaceuticals
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. SCULPT Luxury Dermal Fillers LTD
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. DR. Korman
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Prollenium Medical Technologies
11.2.10.1. Overview
11.2.10.2. Products & Services
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. Suneva Medical
11.2.11.1. Overview
11.2.11.2. Products & Services
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)
11.2.12. Anika Therapeutics, Inc.
11.2.12.1. Overview
11.2.12.2. Products & Services
11.2.12.3. SWOT Analysis
11.2.12.4. Recent Developments
11.2.12.5. Strategies
11.2.12.6. Financials (Based on Availability)

Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 提供ファイル：PDF（印刷不可）
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
    • 同一企業内6名までレポートファイルのご共有が可能です。
  • エンタープライズライセンス
    • 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
    • 同一企業内人数無制限でレポートファイルのご共有が可能です。
• 納品方法
  • Eメール
• 納期
  • レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。

最新調査レポート

• デマンドサイドプラットフォーム（ DSP）地域別の市場規模、シェア、業界分析および予測　2025-2032年
• メッセージングセキュリティ市場規模、シェア、業界分析および予測　2025-2032年
• 皮膚充填剤市場規模、シェア、業界分析および予測　2024-2032年
• ニコチン置換療法（NRT）市場規模、シェア、業界分析および予測　2025-2032年
• フッ素界面活性剤市場規模、シェア、業界分析および予測　2025-2032年

Fortune Business Insights  出版レポート一覧